Vascular dysfunction and increased cardiovascular risk in hypospadias

Abstract

Aims Hypogonadism is associated with cardiovascular disease. However, the cardiovascular impact of hypogonadism during development is unknown. Using hypospadias as a surrogate of hypogonadism, we investigated whether hypospadias is associated with vascular dysfunction and is a risk factor for cardiovascular disease. Methods and results Our human study spanned molecular mechanistic to epidemiological investigations. Clinical vascular phenotyping was performed in adolescents with hypospadias and controls. Small subcutaneous arteries from penile skin from boys undergoing hypospadias repair and controls were isolated and functional studies were assessed by myography. Vascular smooth muscle cells were used to assess: Rho kinase, reactive oxygen species (ROS), nitric oxide synthase/nitric oxide, and DNA damage. Systemic oxidative stress was assessed in plasma and urine. Hospital episode data compared men with a history of hypospadias vs. controls. In adolescents with hypospadias, systolic blood pressure (P = 0.005), pulse pressure (P = 0.03), and carotid intima-media thickness standard deviation scores (P = 0.01) were increased. Arteries from boys with hypospadias demonstrated increased U46619-induced vasoconstriction (P = 0.009) and reduced acetylcholine-induced endothelium-dependent (P < 0.0001) and sodium nitroprusside-induced endothelium-independent vasorelaxation (P < 0.0001). Men born with hypospadias were at increased risk of arrhythmia [odds ratio (OR) 2.8, 95% confidence interval (CI) 1.4–5.6, P = 0.003]; hypertension (OR 4.2, 95% CI 1.5–11.9, P = 0.04); and heart failure (OR 1.9, 95% CI 1.7–114.3, P = 0.02). Conclusion Hypospadias is associated with vascular dysfunction and predisposes to hypertension and cardiovascular disease in adulthood. Underlying mechanisms involve perturbed Rho kinase- and Nox5/ROS-dependent signalling. Our novel findings delineate molecular mechanisms of vascular injury in hypogonadism, and identify hypospadias as a cardiovascular risk factor in males. Key question Is hypospadias associated with vascular dysfunction? Key finding Boys with hypospadias have evidence of hypercontractility and impaired vasodilation secondary to increased Rho kinase activation and oxidative stress. This leads to raised systolic blood pressure in adolescence and increased risk of admission to hospital for cardiovascular diseases in adulthood. Take-home message Hypospadias is a risk factor for cardiovascular dysfunction in males.

Whole-exome sequencing study of hypospadias

“…DNAH11 variants are significantly associated with congenital heart diseases (CHDs). 41 The recent study showed that boys born with hypospadias increased cardiovascular risk, 42 indicating that DNAH11 might be important to understand the pleiotropy between CHDs and hypospadias. In brief, this study improves our understanding of genetic architecture of hypospadias, especially the genetic etiology of core genes in hypospadias.…”

Testosterone promotes human foreskin fibroblast growth through miR-143-3p targeting IGFBP-3

“…GraphPad Prism 8.0 statistical software (Graphpad, La Jolla, CA, USA) was applied for data processing [38]. The Student's t-test and one-way analysis of variance (ANOVA) were used to analyze and calculate the significance of the difference between the different groups.…”

“…Hypospadias is a congenital malformation affecting the external male genitalia, which can lead to hypogonadism and increase the risk of cardiovascular disease in adulthood [38]. Given these phenomena, it is of great significance to explore the pathogenesis of hypospadias.…”

Investigation Driven by Network Pharmacology on Potential Components and Mechanism of DGS, a Natural Vasoprotective Combination, for the Phytotherapy of Coronary Artery Disease

“…Furthermore, the levels of VEGFA and NO secretion in HUVECs were measured, and angiogenic and diastolic-associated proteins were quantified using Western blot. NO is a key cell-signaling molecule that is produced by activated eNOS catalyzing L-arginine [43]. Activation of eNOS and release of NO will induce the vasodilation of vessels, and NO is necessary to maintain endothelial cell function [44].…”